You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Last Updated: February 22, 2024

DARANIDE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Daranide, and when can generic versions of Daranide launch?

Daranide is a drug marketed by Xeris and is included in one NDA.

The generic ingredient in DARANIDE is dichlorphenamide. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dichlorphenamide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Daranide

A generic version of DARANIDE was approved as dichlorphenamide by TORRENT on December 29th, 2022.

  Try a Trial

Drug patent expirations by year for DARANIDE
Recent Clinical Trials for DARANIDE

Identify potential brand extensions & 505(b)(2) entrants

University of RochesterPhase 3
National Institute of Neurological Disorders and Stroke (NINDS)Phase 3

See all DARANIDE clinical trials

Pharmacology for DARANIDE

US Patents and Regulatory Information for DARANIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xeris DARANIDE dichlorphenamide TABLET;ORAL 011366-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.